Pharmesis International Ltd. (SGX:BFK)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.4400
+0.0050 (1.15%)
At close: Jun 3, 2025, 5:00 PM SGT
450.00%
Market Cap 13.95M
Revenue (ttm) 12.65M
Net Income (ttm) 1.55M
Shares Out 31.70M
EPS (ttm) 0.05
PE Ratio 8.49
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Average Volume 200
Open 0.4400
Previous Close 0.4350
Day's Range 0.4400 - 0.4400
52-Week Range 0.0650 - 0.7000
Beta -1.00
RSI 19.58
Earnings Date May 6, 2025

About Pharmesis International

Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the Kinna brand, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arterioscler... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 1,096
Stock Exchange Singapore Exchange
Ticker Symbol BFK
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.